Zytiga Forms Key Part
of Cancer Strategy
Zytiga Forms
Key Part of
Cancer
Strategy

Over the course of his career as a biotechnology investor, Dr.
Lindsay Rosenwald...
Zytiga Forms
Key Part of
Cancer
Strategy

Cougar Biotechnology was bought out by Johnson & Johnson while
Zytiga was still ...
Zytiga Forms
Key Part of
Cancer
Strategy

The need for drugs like Zytiga is growing, as well. Prostate cancer
accounted fo...
Upcoming SlideShare
Loading in …5
×

Zytiga Forms Key Part of Cancer Strategy

322 views
280 views

Published on

Zytiga Forms Key Part of Cancer Strategy

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
322
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Zytiga Forms Key Part of Cancer Strategy

  1. 1. Zytiga Forms Key Part of Cancer Strategy
  2. 2. Zytiga Forms Key Part of Cancer Strategy Over the course of his career as a biotechnology investor, Dr. Lindsay Rosenwald has helped to fund several groundbreaking treatments. At Cougar Biotechnology, Inc., which Dr. Lindsay Rosenwald co-founded, he helped to push the drug Zytiga through two stages of clinical trials.
  3. 3. Zytiga Forms Key Part of Cancer Strategy Cougar Biotechnology was bought out by Johnson & Johnson while Zytiga was still under development. The drug is now an important part of the company’s strategy in cancer therapeutics. Zytiga , which is approved to treat chemotherapy-naïve metastatic-castrationresistant prostate cancer and chemo-refractory metastaticcastration-resistant prostate cancer, accounts for nearly one-third of the market for drugs of its type in the United States.
  4. 4. Zytiga Forms Key Part of Cancer Strategy The need for drugs like Zytiga is growing, as well. Prostate cancer accounted for 14 percent of cancer diagnosed in men worldwide in 2008. The disease is primarily diagnosed in developed countries where Johnson & Johnson has experience in operating. Overall, cancer diagnoses are expected to grow significantly in the next several decades.

×